1478 related articles for article (PubMed ID: 19757346)
1. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
[TBL] [Abstract][Full Text] [Related]
2. [Surgical treatment of gasto-esophageal junction adenocarcinoma: long-term results of a single Italian centre].
Pedrazzani C; Pasini F; Giacopuzzi S; Bernini M; Ruzzenente A; Festini M; Tomasi I; Cristadoro L; de Manzoni G
G Chir; 2004 Oct; 25(10):325-33. PubMed ID: 15756954
[TBL] [Abstract][Full Text] [Related]
3. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
[TBL] [Abstract][Full Text] [Related]
5. Individualized surgical strategies for cancer of the esophagogastric junction.
Stein HJ; Feith M; Siewert JR
Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
[TBL] [Abstract][Full Text] [Related]
6. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
[TBL] [Abstract][Full Text] [Related]
7. Adenocarcinoma of the esophagogastric junction: the role of abdominal-transhiatal resection.
Carboni F; Lorusso R; Santoro R; Lepiane P; Mancini P; Sperduti I; Santoro E
Ann Surg Oncol; 2009 Feb; 16(2):304-10. PubMed ID: 19050964
[TBL] [Abstract][Full Text] [Related]
8. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.
Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
Ann Surg Oncol; 2007 Feb; 14(2):306-16. PubMed ID: 17091329
[TBL] [Abstract][Full Text] [Related]
9. Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogastric junction.
von Rahden BH; Stein HJ; Feith M; Becker K; Siewert JR
J Clin Oncol; 2005 Feb; 23(4):874-9. PubMed ID: 15681533
[TBL] [Abstract][Full Text] [Related]
10. Surgical approach and results of surgery in adenocarcinoma of the gastro-oesophageal junction.
Ti TK
Singapore Med J; 2000 Jan; 41(1):14-8. PubMed ID: 10783674
[TBL] [Abstract][Full Text] [Related]
11. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
Ielpo B; Pernaute AS; Elia S; Buonomo OC; Valladares LD; Aguirre EP; Petrella G; Garcia AT
Interact Cardiovasc Thorac Surg; 2010 May; 10(5):704-8. PubMed ID: 20154347
[TBL] [Abstract][Full Text] [Related]
12. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients.
Feith M; Stein HJ; Siewert JR
Surg Oncol Clin N Am; 2006 Oct; 15(4):751-64. PubMed ID: 17030271
[TBL] [Abstract][Full Text] [Related]
13. Outcome of patients with cancer of the esophagogastric junction in relation to histology and surgical strategy.
Gianotti L; Braga M; Landoni L; Mari G; Scaltrini F; Di Castelnuovo A; Di Carlo V
Hepatogastroenterology; 2003; 50(54):1948-52. PubMed ID: 14696439
[TBL] [Abstract][Full Text] [Related]
14. Surgical therapy of adenocarcinoma of the esophagogastric junction: analysis of prognostic factors.
Di Martino N; Izzo G; Cosenza A; Cerullo G; Torelli F; Monaco L; Basciotti A; del Genio A
Hepatogastroenterology; 2005; 52(64):1110-5. PubMed ID: 16001641
[TBL] [Abstract][Full Text] [Related]
15. Classification, diagnosis and surgical treatment of carcinomas of the gastroesophageal junction.
Mönig SP; Schröder W; Beckurts KT; Hölscher AH
Hepatogastroenterology; 2001; 48(41):1231-7. PubMed ID: 11677937
[TBL] [Abstract][Full Text] [Related]
16. [Whole laparoacopic trans-hiatal extended total gastrectomy with the Or-Vil device: preliminary results in the treatment of Siewert type II and III tumors].
Siani LM; Ferranti F; Marzano M; Benedetti M; Quintiliani A
Chir Ital; 2009; 61(3):289-94. PubMed ID: 19694230
[TBL] [Abstract][Full Text] [Related]
17. Esophagogastric junction adenocarcinoma according to Siewert classification in Taiwan.
Fang WL; Wu CW; Chen JH; Lo SS; Hsieh MC; Shen KH; Hsu WH; Li AF; Lui WY
Ann Surg Oncol; 2009 Dec; 16(12):3237-44. PubMed ID: 19636628
[TBL] [Abstract][Full Text] [Related]
18. Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction.
Mine S; Sano T; Hiki N; Yamada K; Kosuga T; Nunobe S; Yamaguchi T
Br J Surg; 2013 Jul; 100(8):1050-4. PubMed ID: 23754647
[TBL] [Abstract][Full Text] [Related]
19. Association of perioperative fluid balance and adverse surgical outcomes in esophageal cancer and esophagogastric junction cancer.
Wei S; Tian J; Song X; Chen Y
Ann Thorac Surg; 2008 Jul; 86(1):266-72. PubMed ID: 18573435
[TBL] [Abstract][Full Text] [Related]
20. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.
Omloo JM; Lagarde SM; Hulscher JB; Reitsma JB; Fockens P; van Dekken H; Ten Kate FJ; Obertop H; Tilanus HW; van Lanschot JJ
Ann Surg; 2007 Dec; 246(6):992-1000; discussion 1000-1. PubMed ID: 18043101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
